Comparison of heart failure risk assessment tools among cancer survivors
HFA-ICOS and ARIC-HF outperformed the PCP-HF among cancer- and non-cancer cohort, although all showed modest discrimination for incident HF to be applied to clinical practice. A cancer-specific HF prediction tool could facilitate HF prevention among survivors.
Authors
- Cheng Hwee Soh (ORCID: https://orcid.org/0000-0001-8056-7354)
- Thomas Hugh Marwick (ORCID: https://orcid.org/0000-0001-9065-0899)
Institutions
- Baker Heart and Diabetes Institute (AU)
- Menzies School of Health Research (AU)
- Baker Engineering (United States) (US)
- Melbourne Health (AU)
Publication Details
- Journal
- Cardio-Oncology
- Published
- 2024-10-11
- DOI
- https://doi.org/10.1186/s40959-024-00267-5
- Citations
- 4
- Primary Topic
- Chemotherapy-induced cardiotoxicity and mitigation
- Type
- article
- Field-Weighted Citation Impact
- 1.61
Funders
- National Health and Medical Research Council